Stronger Sell Today CLSD ranks #5627 as SELL CANDIDATE. Weaker Sell
Today CLSD ranks #5627 as SELL CANDIDATE.

CLSD stock Clearside BioMedical, Inc

CLSD stock
Clearside BioMedical, Inc

Wed 12'th Dec 2018

PERIOD 2018-09-13 - 2018-12-12
CHANGE -1.46%




Request Prediction

Clearside BioMedical, Inc Stock Analysis

Technical stock analysis for Wed 12'th Dec 2018

Sell candidate since 2018-11-02 Loss -75.72%
Shorts n/a
Cash n/a
Loans n/a
Beta -3.58
ROA -125.02

Clearside BioMedical, Inc fell by -1.46% in the last day from $1.37 to $1.35 and has now fallen 3 days in a row. The price has fallen in 6 of the last 10 days and is down by -11.18% for this period. Volume has increased in the last day by 101 532 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 341 482 shares bought and sold for approximately $461 001.00.


Clearside BioMedical, Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -66.57% during the next 3 months and, with 90% probability hold a price between $-0.18 and $1.09 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Clearside BioMedical, Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.40 and $2.65. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Monday December 10, 2018, which indicates further falls until a new bottom pivot has been found. Clearside BioMedical, Inc gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 28 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

Price: $1.35 Resistance: $1.50


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.08 between high and low, or 6.06%. For the last week, the stock has had a daily average volatility of 9.46%.

Clearside BioMedical, Inc is oversold on RSI14 (28). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


Clearside BioMedical, Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today CLSD ranks #5627 as SELL CANDIDATE. Weaker Sell
Today CLSD ranks #5627 as SELL CANDIDATE.